FWM
NVAX icon

Focused Wealth Management’s Novavax NVAX Stock Holding History

Focused Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33
Closed -$158 – 695
2023
Q4 		$158 Sell
33
-326
-91% -$2K ﹤0.01% 961
2023
Q3 		$2.6K Sell
359
-280
-44% -$2.24K ﹤0.01% 737
2023
Q2 		$4.75K Hold
639
– – ﹤0.01% 679
2023
Q1 		$4.43K Hold
639
– – ﹤0.01% 695
2022
Q4 		$6.57K Hold
639
– – ﹤0.01% 597
2022
Q3 		$12K Hold
639
– – ﹤0.01% 466
2022
Q2 		$33K Buy
639
+33
+5% +$1.71K 0.01% 334
2022
Q1 		$45K Buy
+606
New +$54K 0.01% 323
2016
Q4 		– Sell
-50
Closed -$2K – 722
2016
Q3 		$2K Hold
50
– – ﹤0.01% 591
2016
Q2 		$7K Buy
50
+25
+100% +$2.87K ﹤0.01% 480
2016
Q1 		$3K Hold
25
– – ﹤0.01% 532
2015
Q4 		$4K Hold
25
– – ﹤0.01% 535
2015
Q3 		$4K Buy
+25
New +$5.61K ﹤0.01% 524

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Focused Wealth Management's NVAX Position: Q1 2024 in Review

Focused Wealth Management sold out of Novavax (NVAX) in Q1 2024, closing a stake of 33 shares — an estimated $158 sold.

Focused Wealth Management first reported a position in NVAX in Q3 2015 and held it in 13 quarters. The position peaked at $45K in Q1 2022. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • Focused Wealth Management reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 33 Novavax shares in Q1 2024, an estimated $158.
  • Focused Wealth Management first reported a position in Novavax in Q3 2015 and held it in 13 quarters.
  • Focused Wealth Management's Novavax position peaked at $45K in Q1 2022.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.